N-substituted P-menthane carboxamides

Information

  • Patent Grant
  • RE44339
  • Patent Number
    RE44,339
  • Date Filed
    Wednesday, August 31, 2011
    13 years ago
  • Date Issued
    Tuesday, July 2, 2013
    11 years ago
Abstract
Cooling compounds are provided having the formula:
Description
COOLING COMPOUNDS ARE PRESENTED

Cooling compounds, that is, chemical compounds that impart a cooling sensation to the skin or the mucous membranes of the body, are well known to the art and are widely used in a variety of products such as foodstuffs, tobacco products, beverages, dentifrices, mouthwashes and toiletries.


One class of cooling compounds that have enjoyed substantial success consists of N-substituted p-menthane carboxamides. Examples of these compounds are described in, for example, British Patents GB 1,351,761-2 and U.S. Pat. No. 4,150,052.


It has now been found that a particular selection of such compounds exhibits a cooling effect that is both surprisingly strong and long-lasting. In one embodiment, the cooling compounds can be represented by formula I




embedded image



in which m is 0 or 1, Y and Z are selected independently from the group consisting of H, OH, C1-C4 straight or branched alkyl, and a C1-C4 straight or branched alkoxy; X is (CH2)n—R, where n is 0 or 1 and R is a group with non-bonding electrons, with the provisos that:

  • (a) when Y and Z are H, X is not F, OH, MeO or NO2 in the 4-position and is not OH in the 2 or 6-position
  • (b) when Y or Z is H then X, Y and Z are such that
    • (i) the groups in the 3- and 4-positions are not both OMe,
    • (ii) the groups in the 4- and 5-positions are not both OMe,
    • (iii) the groups in 3- and 5-positions are not OMe if the group in the 4-position is OH, and
    • (iv) the groups in the 3- and 5-positions are not OH if the group in the 4-position is methyl.


An embodiment provides for compounds of formula I wherein X is in the 4-position. Additional embodiments provide for compounds of formula I wherein X is in the 4-position and Y and Z are H, OH, Me or OMe. In certain embodiments, Y and Z are selected independently.


Useful groups with non-bonding electrons are halogens, OH, OMe, NO2, CN, Ac, SO2NH2, CHO, CO2H and C1-C4 alkyl carboxylates such as CO2Et. Other C1-C4 alkyl carboxylates with non-bonding electrons may be useful.


The compounds of formula I have 3 chiral centres, giving rise to 8 stereoisomers. All possible stereoisomers are included in the scope of the compounds represented by formula I.


The cooling compounds may be prepared by reacting an arylalkylamine derivative with an appropriate acid chloride or carbonyl chloride. The carbonyl chloride can be prepared from 1-menthol ((1R,2S,5R)-2-isopropyl-5-methylcyclohexanol).


The cooling compounds are distinguished from similar compounds of the prior art by their surprisingly high cooling effect (up to 10 times higher than that of similar known compounds) and by the longevity of the cooling effect, which adds to their attractiveness in a large variety of products.


For example, a small group of panelists was asked to taste various solutions of cooling compounds and indicate which solutions had a cooling intensity similar or slightly higher than that of a solution of menthol at 2 ppm. In a second experiment, the same panel was asked to taste the solutions at the chosen concentrations and to record the cooling intensity at regular time intervals until no cooling could be sensed in the mouth. Results are shown in table 1.









TABLE 1







experiment on cooling intensity and longevity.









Chemical
Concentration
Longevity





1-Menthol
2.0 ppm
35 minutes


N-ethyl p-menthanecarboxamide (WS-3)
1.5 ppm
57 minutes


Formula 1, m = 0,Y = Z = H,
0.5 ppm
90 minutes


X = 4-CN




Formula 1, m = 0, Y = Z = H,
0.2 ppm
93 minutes


X = 4-CH2CN









From Table 1, it can be seen that the compounds of Formula I are up to 10 times stronger and last up to 3 times longer than menthol, the reference cooling compound. Compounds of Formula I are also much stronger and last longer than WS-3, a known cooling compound of the prior art.


The subject cooling compounds may be used in products that are applied to the mouth or the skin to give a cooling sensation. By “applying” is meant any form of bringing into contact, for example, oral ingestion or, in the case of tobacco products, inhalation. In the case of application to the skin, it may be, for example, by including the compound in a cream or salve, or in a sprayable composition. A method is directed to providing a cooling effect to the mouth or skin by applying thereto a product comprising a compound as hereinabove described.


The subject cooling compounds may be used alone or in combination with other cooling compounds known in the art, e.g., menthol, menthone, isopulegol, N-ethyl p-menthanecarboxamide (WS-3), N,2,3-trimethyl-2-isopropylbutanamide (WS-23), menthyl lactate (Frescolat™ ML), menthone glycerine acetal (Frescolat™ MGA), mono-menthyl succinate (Physcool™), mono-menthyl glutarate, O-menthyl glycerine (CoolAct™ 10), menthyl-N,N-dimethylsuccinamate or 2-sec-butylcyclohexanone (Freskomenthe™).


The subject cooling compounds and related methods are further described by the following non-limiting examples.


The starting compound p-menthane-3-carbonyl chloride as used for the preparation of the compounds in Example 1-6 was prepared from 1-menthol.







EXAMPLE 1
Preparation of N-(4-cyanomethylphenyl) p-menthanecarboxamide

To a flask, were added 6.6 g (50 mmol) of 4-aminobenzyl cyanide, 4.04 mL of pyridine and 100 mL MtBE. To this mixture, 10 g of p-menthane-3-carbon*yl chloride were added dropwise over 5 minutes. The reaction mixture was stirred for 24 h. To the reaction mixture, 50 mL of water were added. The mixture was separated. The organic layer was washed with 50 mL of water and 50 mL of brine. The organic layer was dried over MgSO4. The solvent was evaporated in vacuo to afford the crude product, which was recrystallized from hexanes to afford 10.1 g of the desired product with the following spectroscopic properties:


MS: 299 ([M+1]), 298 ([M+]), 132, 83. 1H NMR (300 MHz; CDCl3) δ; 7.58 (d, 2H), 7.49 (s, 1H), 7.27 (d, 2H), 3.73 (s, 2H), 2.2 (t, 1H), 1.96-1.57 (m, 5H), 1.48-1.21 (m, 2H), 1.172-0.99 (m, 2H), 0.94 (d, 3H), 0.93 (d, 3H), 0.85 (d, 3H). 13C NMR (75 MHz; CDCl3)δ: 174.4, 137.8, 128.3, 125.1, 120.3, 118.2, 50.5, 44.3, 39.25, 34.3, 32.1, 28.7, 23.8, 22.9, 22.1, 21.2, 16.1


EXAMPLE 2
Preparation of N-(4-sulfamoylphenyl) p-menthanecarboxamide

A preparation similar to that described in example 1 gives the desired product with the following spectroscopic properties:


MS: 339 ([M+1]), 338 ([M+]), 172, 83. 1H NMR (300 MHz; DMSO) δ: 10.21 (s, 1H), 7.76 (d, 1H) 7.73 (d, 2H), 7.23 (s, 2H), 2.26-2.42 (m, 1H), 1.45-1.85 (m, 5H), 1.29-1.44 (m, 2H), 0.89 (d, 3H), 0.86 (d, 3H), 0.78 (d, 3H). 13C NMR (75 MHz; DMSO) δ: 174.6, 142.3, 138.3, 126.7, 118.8, 48.9, 43.7, 34.3, 31.9, 28.6, 23.7, 22.35, 21.3, 16.25


EXAMPLE 3
Preparation of N-(4-cyanophenyl) p-menthanecarboxamide

A preparation similar to that described in example 1 gives the desired product with the following spectroscopic properties:


MS: 285 ([M+1]), 284 ([M+]), 139, 83. 1H NMR (300 MHz; CDCl3) δ: 7.69 (d, 2H), 7.6 (d, 2 H), 7.5 (s, 1H), 1.85-1.97 (m, 1H), 1.69-1.84 (m, 3H), 1.55-1.69 (m, 2H), 1.21-1.47 (m, 2H), 0.979-1.16 (m, 2H), 0.95 (d, 3H), 0.93 (d, 3H), 0.82 (d, 3H). 13C NMR (300 MHz; CDCl3) δ: 174.6, 133.1, 119.4, 118.7, 100.35, 50.7, 44.4, 39.25, 34.2, 32.1, 28.8, 23.7, 22.0, 21.2, 16.1, 14.0


EXAMPLE 4
Preparation of N-(4-acetylphenyl) p-menthanecarboxamide

A preparation similar to that described in example 1 gives the desired product with the following spectroscopic properties:


MS: 302 ([M+1]), 301 ([M+]), 135, 83. 1H NMR (300 MHz; CDCl3) δ: 7.93 (d, 2H), 7.66 (d, 2H), 7.63 (s, 1H), 2.57 (s, 3H), 2.09-2.31 (m, 1H), 1.84-1.98 (m, 1H), 1.68-1.85 (m, 5H), 1.56-1.68 (m, 1H), 1.17-1.48 (m, 2H), ), 0.93 (d, 3H), 0.91 (d, 3H), 0.83 (d, 3H). 13C NMR (75 MHz; CDCl3) δ: 197.1, 174.9, 142.7, 129.9, 119.2, 51.2, 44.9, 39.8, 34.8, 32.6, 29.2, 26.6, 24.3, 22.4, 21.5, 16.6


EXAMPLE 5
Preparation of N-(4-hydroxymethylphenyl) p-menthanecarboxamide

A preparation similar to that described in example 1 gives the desired product with the following spectroscopic properties:


MS: 290 (M+1), 289 (M+), 123, 83. 1HNMR (300 MHz, DMSO) δ: 9.9 (s, 1H), 7.54 (d, 2H), 7.21 (d, 2H), 4.2 (s, 2H), 2.36-2.1 (m, 1H), 1.8-1.59 (m, 6H), 1.57-1.44 (m, 1H), 1.21-0.9 (m, 4H), 0.87 (dd, 3H), 0.85 (dd, 3H), 0.79 (d, 2H). 13C NMR (75 MHz; DMSO) δ: 173.7, 137.7, 137.1, 126.7, 118.9, 62.6, 48.6, 43.6, 34.2, 31.7, 28.3, 23.6, 22.2, 21.1, 16.1


EXAMPLE 6
Preparation of N-(3-hydroxy-4-methoxyphenyl) p-menthanecarboxamide

A preparation similar to that described in example 1 gives the desired product with the following spectroscopic properties:


MS: 306 ([M+1]), 305 ([M+]), 139, 83. 1H NMR (300 MHz; CDCl3) δ: 7.14 (s, 1H), 7.08 (d, 1H), 6.78 (d, 1H), 5.7 (s, 1H), 3.8 (s, 3H), 2.02-2.21 (m, 2H), 1.53-1.94 (m, 5H), 1.17-1.48 (m, 2H), 0.97-1.17 (m, 2H), 0.92 (dd, 3H), 0.91 (dd, 3H), 0.82 (d, 3H). 13C NMR (75 MHz; CDCl3) δ: 173.9, 145.6, 143.3, 131.7, 111.65, 110.8, 107.4, 56.1, 50.5, 44.4, 39.2, 32.15, 34.4, 28.6, 23.8, 22.1, 21.2, 16.1


EXAMPLE 7
Application in Mouthwash


















Alcohol 95%
177
mL



Sorbitol 70%
250
g



Compound of example 1 as a 1% solution in alcohol
50
mL



Peppermint oil, Terpeneless
0.300
g



Methyl salicylate
0.640
g



Eucalyptol
0.922
g



Thymol
0.639
g



Benzoic acid
1.500
g



Pluronic ™ F127
5.000
g



Sodium Saccharin
0.600
g



Sodium Citrate
0.300
g



Citric Acid
0.100
g



Water
q.s. 1
liter










The ingredients are mixed. 30 mL of obtained solution is put in the mouth, swished around, gargled and spit out. An intense cooling is felt in every area of the mouth as well as the lips. The cooling perception lasts for several hours.


EXAMPLE 9
Application in Toothpaste

Opaque toothgel 97.000 g


Compound of example 2 as a 2% solution in PG 2.500 g


Peppermint oil, Terpeneless 0.500 g


The materials are mixed in the toothgel, and a panelist's teeth are brushed using this toothgel. The mouth is rinsed with water and the water spit out. An intense cooling sensation is felt by the panelist in all areas of the mouth. The cooling perception lasts for several hours.


It will be understood that the embodiments described herein are merely exemplary, and that one skilled in the art may make variations and modifications without departing from the spirit and scope of the invention. All such variations and modifications are intended to be included within the scope of the invention as described hereinabove. Further, all embodiments disclosed are not necessarily in the alternative, as various embodiments of the invention may be combined to provide the desired result.

Claims
  • 1. A compound selected from the group consisting of N-(4-cyanomethylphenyl) p-menthanecarboxamide, N-(4-sulfamoylphenyl) p-menthanecarboxamide, N-(4-cyanophenyl) p-menthanecarboxamide, N-(4-acetylphenyl) p-menthanecarboxamide, N-(4-hydroxymethylphenyl) p-menthanecarboxamide and N-(3-hydroxy-4-methoxyphenyl) p-menthanecarboxamide.
  • 2. A method of providing a cooling effect to the mouth or skin by applying thereto a product comprising a compound according to claim 1selected from the group consisting of N-(4-cyanomethylphenyl) p-menthanecarboxamide, N-(4-sulfamoylphenyl) p-menthanecarboxamide, N-(4-cyanophenyl) p-menthanecarboxamide, N-(4-acetylphenyl) p-menthanecarboxamide, N-(4-hydroxymethylphenyl) p-menthanecarboxamide and N-(3-hydroxy-4-methoxyphenyl) p-menthanecarboxamide.
  • 3. A product that is applied to the mouth or the skinfoodstuff, tobacco product, beverage, dentrifice, mouthwash, or toiletry composition comprising an amount of a compound according to claim 1selected from the group consisting of N-(4-cyanomethylphenyl) p-menthanecarboxamide, N-(4-sulfamoylphenyl) p-menthanecarboxamide, N-(4-cyanophenyl) p-menthanecarboxamide, N-(4-acetylphenyl) p-menthanecarboxamide, N-(4-hydroxymethylphenyl) p-menthanecarboxamide and N-(3-hydroxy-4-methoxyphenyl) p-menthanecarboxamide, wherein the amount is effective to give a cooling sensation to the mouth or the skin.
  • 4. A compound comprising formula I
  • 5. A method of providing a cooling effect to the mouth or skin by applying thereto a product comprising a compound according to claim 4.
  • 6. A product that is applied to the mouth or the skin comprising an amount of a compound according to claim 4, wherein the amount is effective to give a cooling sensation to the mouth or the skin.
  • 7. The product of claim 6 comprising at least one of foodstuffs, tobacco products, beverages, dentifrices, mouthwashes, or toiletries.
  • 8. The productcomposition of claim 7 comprising3 wherein the product comprises a cream or salve.
  • 9. The productcomposition of claim 7 comprising3 wherein the product comprises a sprayable composition.
  • 10. The product of claim 6 further comprising an additional cooling compound.
  • 11. The product of claim 10 wherein the additional cooling compound comprises at least one of menthol, menthone, isopulegol, N-ethyl p-menthanecarboxamide, N,2,3-trimethyl-2-isopropylbutanamide, menthyl lactate, menthone glycerine acetal, mono-menthyl succinate, mono-menthyl glutarate, O-menthyl glycerine, menthyl-N,N-dimethylsuccinamate or 2-sec-butylcyclohexanone.
  • 12. The method of claim 5 wherein said applying comprises inhalation.
  • 13. The method of claim 5 wherein said applying comprises oral ingestion.
  • 14. The product of claim 3 comprising at least one of foodstuffs, tobacco products, beverages, dentifrices, mouthwashes, or toiletries.
  • 15. The product of claim 14 comprising a cream or salve.
  • 16. The product of claim 14 comprising a sprayable composition.
  • 17. The productcomposition of claim 3 further comprising an additional cooling compound.
  • 18. The productcomposition of claim 17 wherein the additional cooling compound comprises at least one of menthol, menthone, isopulegol, N-ethyl p-menthanecarboxamide, N,2,3-trimethyl-2-i sopropylbutanami de, menthyl lactate, menthone glycerine acetal, mono-menthyl succinate, mono-menthyl glutarate, O-menthyl glycerine, menthyl-N,N-dimethylsuccinamate or 2-sec-butylcyclohexanone.
  • 19. The method of claim 2 wherein said applying comprises inhalation.
  • 20. The method of claim 2 wherein said applying comprises oral ingestion.
  • 21. The compound of claim 1, wherein said compound is N-(4-cyanomethylphenyl) p-menthanecarboxamide.
  • 22. The method of claim 2, wherein said compound is N-(4-cyanomethylphenyl) p-menthanecarboxamide.
  • 23. The composition of claim 3, wherein said compound is N-(4-cyanomethylphenyl) p-menthanecarboxamide.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a reissue application of U.S. Ser. No. 11/437,294 filed May 19, 2006, now U.S. Pat. No. 7,414,152, which is a continuation-in-part of International Application No. PCT/CH2004/000646 filed Oct. 28, 2004, under 35 USC §120 and §365(c), and which claims the benefit of the filing date of U.S. Provisional Application No. 60/523,977 filed Nov. 21, 2003.

US Referenced Citations (19)
Number Name Date Kind
4136163 Watson et al. Jan 1979 A
4150052 Watson et al. Apr 1979 A
4226988 Watson et al. Oct 1980 A
4248859 Rowsell et al. Feb 1981 A
4296093 Rowsell et al. Oct 1981 A
4318900 Rowsell et al. Mar 1982 A
6348625 Anderson Feb 2002 B1
6399614 Leonardi et al. Jun 2002 B1
20050084447 Wei Apr 2005 A1
20050159394 Wei Jul 2005 A1
20050187211 Wei Aug 2005 A1
20050207993 Bazemore et al. Sep 2005 A1
20060051301 Galopin et al. Mar 2006 A1
20080112899 Galopin et al. May 2008 A1
20080176945 Galopin et al. Jul 2008 A1
20080305051 Cole et al. Dec 2008 A1
20080319055 Cole et al. Dec 2008 A1
20090105237 Bell et al. Apr 2009 A1
20100035938 Bell et al. Feb 2010 A1
Foreign Referenced Citations (16)
Number Date Country
1351761 May 1974 GB
1351762 May 1974 GB
1353381 May 1974 GB
1421744 Jan 1976 GB
1457671 Dec 1976 GB
WO 2004089416 Oct 2004 WO
WO 2005002582 Jan 2005 WO
WO 2005015158 Feb 2005 WO
WO 2005020897 Mar 2005 WO
WO 2006056087 Jun 2006 WO
WO 2006056096 Jun 2006 WO
WO 2006092074 Sep 2006 WO
WO 2006099762 Sep 2006 WO
WO 2006125334 Nov 2006 WO
WO 2007019719 Feb 2007 WO
WO 20090070910 Jun 2009 WO
Non-Patent Literature Citations (10)
Entry
Watson H.R., et al., “New Compounds with the Menthol Cooling Effect,” Journal of Society of Cosmetic Chemists, New York, NY, U.S., vol. 29, No. 4, 1978, pp. 185-200.
Database Chemicals [Online], Chemical Abstracts Service, Columbus, Ohio, US; Jan. 12, 2005, XP002382088, retrieved from STN, order No. 6489078, abstract.
Database Chemcats, Chemical Abstracts Service, Columbus, Ohio, US; Jan. 18, 2005, XP002382089, order No. STK013323, abstract.
Database Chemcats, Chemical Abstracts Service, Columbus, Ohio, US; Jan. 18, 2005, XP002382090, order No. BAS 08858028, abstract.
Database Chemcats, Chemical Abstracts Service, Columbus, Ohio, US; Jan. 12, 2005, XP002382091, order No. 6383438, abstract.
Database Chemcats, Chemical Abstracts Service, Columbus, Ohio, US; Jan. 12, 2005, XP002382092, order No. 6399044, abstract.
Database Beilstein, Beilstein Insitut zur Förderung der Chemischen Wissenschaften; XP002382093 accession No. 3422960, abstract & BUU-HOI: Z. Physiol. Chem., vol. 279, 1943.
Database Beilstein, Beilstein Institut zur Förderung der Chemischen Wissenschaften; XP002382094 accession No. 2328224, abstract & Inagaki, Shingaki: Chem. Lett., 1981.
Database Chemcats, Accession NR. 2004:1396439: ChemBridge Screening Library, Order NR. 5380996, Jan. 12, 2005, XP 002384344, abstract.
Patani et al., Chemical Review, 1996, vol. 96, pp. 3147-3176.
Provisional Applications (1)
Number Date Country
60523977 Nov 2003 US
Continuation in Parts (1)
Number Date Country
Parent PCT/CH2004/000646 Oct 2004 US
Child 11437294 US
Reissues (1)
Number Date Country
Parent 11437294 May 2006 US
Child 13222947 US